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l
Summary: Glycogen phosphorylase isoenzyme BB mass release was studied in 20 patients undergoing coronary
artery bypass grafting. In 16 patients with uneventful coronary arteiy bypass grafting, glycogen phosphorylase
isoenzyme BB mass concentrations showed a significant, transient increase in the post cross-clamping period and
: decreased to baseline values within 20 hours (peak concentrations ranged firom 12.7 g/l to 47.5 g/l, median 40
! g/l). One patient did not fulfil criteria for perioperative myocardial infarction, but clinical data indicated myocardial
l injury after aortic unclamping. In this patient only glycogen phosphorylase isoenzyme BB mass concentration and
not creatine kinase isoenzyme MB catalytic concentration was increased, compared with uneventful patients. In 2
patients with emergency coronary artery bypass grafting for evolving myocardial infarction, glycogen phosphorylase
isoenzyme BB mass concentrations, but not creatine kinase isoenzyme MB catalytic concentrations, correlated with
clinical evidence of myocardial ischaemia. Our data indicate that glycogen phosphorylase isoenzyme BB mass
concentration is a very sensitive laboratory marker of perioperative myocardial injury in patients undergoing coron-
ary artery bypass grafting.
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myocardium, where it is the predommant isotype. Skele^· ·
tal muscle, by contrast, conteins only isoenzyme MM
(1). Glycogenplysis is stfongly accelerated in ischaemic Methods
myocardium, and ischaemic myoeardium releases sig-
nificant amoünts of glycogen phosphorylase isoenzyme
BB into the systemic'circulatkm (2, 3, 4). Increased gly- ^ institutional approval and infoniied consent 20 consecutive
:_ . v ' ' / ^ patients (17 men, 3 women) undergoing coronary artery bypass
COgen phosphorylase isoenzyme BB mass concentra- grafting were investigated. The median age was 60.5 years (ränge:
tions are a very early laboratory marker of myocardial 45-76 years). Eighteen patients underwent elective coronary ar-
infarction in non-surgical patients (5). The aim of this ^ byPass 8«^ th! «"»»^ 2 ^  emergency coronary
^
 v
 ' artery bypass grafting for evolvmg myocardial infarction. Fmeen
__^ . of the 20 patients had a history of previous myocardial infarction.
"~ " In 4 patients the preoperative left ventricular ejection fraction was
') Enzymes: below 45%. Indicatipns for surgical revascularisation were left
Creatine kinase, EC 2.7,3.2. main coronary artery Stenosis in 7 and three vessel disease in 13
Glycogen phosphorylase BC 2.4.1.1. patients. On average, 3.6 grafts (ränge: 2-5) per patient were im-
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planted. The internal mammary artery was used äs a bypass vessel
in 11 patients. Perioperative myocardial infarction was diagnosed
when creatine1) kinase isoenzyme MB catalytic concentration ex-
ceeded 50 U/l 20 hours after aortic unclamping (6) and electrocar-
diography indicated new myocardial ischaemia. Serial venous
blood samples were collected before surgery, before cardiopulmo-
nary bypass, with aortic unclamping, l, 2, 3, 4, 8, 12, 16, 20, 24,
36 and 48 hours later.
Standard cardiopulmonary bypass technique with moderate sys-
temic hypothermia and aortic crossclamping was used in all pa-
tients. Mediän aortic crossclamping time was 55 minutes (ränge:
36—83 minutes). Myocardial protection during aortic crossclamp^
ing was achieved by infusion of cold cristalloid cardioplegic solu-
tion (St Thomas solution) into the aortic root and by additional
topical cooling.
Laboratory analysis
Creatine kinase and creatine kinase isoenzyme MB catalytic con-
centrations were measured at 25 °C with a Merck test kit (Darm-
stadt, Germany). Creatine kinase isoenzyme MB was measured by
immunoinhibition. The upper limits of the reference interval of
creatine kinase in non-surgical patients are 70 U/l for women and
80 U/l for men. The normal ränge of creatine kinase isoenzyme MB
catalytic cpncentration is below 10 U/l. Glycogen phosphorylase
isoenzyme BB mass concentrations were determined by a recently
developed sensitive immunoenzymometric assay, which is based
on 2 monoclonal antibodies that are highiy specific for glycogen
phosphorylase isoenzyme BB (7). The median glycogen phospho-
rylase isoenzyme BB plasma concentration in a control population
with chronic stable coronary artery disease (21 male, 10 female,
median age 66 years) was 3.9 g/l (ränge: 1.1 g/l—6.5 g/l).
Statistics
Median and interquartile ränge were calculated to describe con-
tinuous variables. Mann Whitney U and Wilcoxon signed rank tests
were used for statistical anaiysis. Spearman rank correlation coeffl··
cients were calculated to describe the assöciation between vari-
ables. A p value < 0.05 was assumed to indicate statistical signifi-
cance.
Results
Glycogen phosphorylase isoenzyme BB
concentrations in patients with elective
coronary artery bypass grafting
Sixteen patients undergoing elective coronary artery by-
pass grafting had an uneventful perioperative course. All
16 patients had creatine kinase isoenzyme MB catalytic
concentrations < 50 U/l 20 hours after aortic unclamp-
ing, and no patient developed new Q waves periopera-
tively. None of the 16 patients .showed postbypass
cardiac failure and all were weaned from extracorporeal
circulation without inotropic support (dopamine dosis
< 5 g/kg · min). Creatine kinase isoenzyme MB cata-
lytic concentrations in these uneventful patients signifi-
cantly (p = 0.01) increased three hours after aortic un-
clamping (median peak concentration 18 U/l, ränge:
4 U/1-27 U/l) and stayed elevated for 20 hours. Glyco-
gen phosphorylase isoenzyme BB mass concentrations
in these 16 patients significantly increased (p = 0.01)
after aortic unclamping äs well, remained high for 4
hours (median peak concentration 40 g/l,, ränge: 12.7
g/l-47.5 g/l) and decreased to baseline values within
20 hours after aortic unclamping (see fig. 1). In contrast
to creatine kinase isoenzyme MB catalytic concentration
peaks (p = 0.34, p = 0.3)* glycogen phosphorylase iso-
enzyme BB mass concentration peaks (p = 0.59,
p = 0.03) of these 16 patients corfelated with aortic
crossclamping time.
One patient (patient b, fig. 1) did not fulfil the criteria
for perioperative myocardial infarction (creatine kinase
isoenzyme MB catalytic concentration peak 27 U/l 8
hours after aortic unclamping), but developed cardiac
failure in the post cross-clarnping period despite pro- g
longed reperfusion on extracorporeal circulation. Periop- i1·
erative electrocardiographic monitoring for myocardial '!
ischaemia was non-diagriostic in this patient, because of
a preexisting left bündle branch block. Preoperative left
ventricular function was only mildly impaired (left ven-
tricular enddiastolic pressure: 6 mm Hg, left ventricular
ejection fraction: 46%) and the aortic crossclamping
time was only 65 minutes. Surgery, however, was com-
plicated by thrombendarterectomy of the left anterior
descending coronary artery. The patient could be weaned
from extracorporeal circulation only with high dose ino^
tropic support (adrenaline 17 ^/kg · min, amrinone 350
g/kg · min). Left ventricular funetion improved post-
operatively and the patient was weaned from catechola-
mine therapy within 24 hours. In contrast to creatine
kinase isoenzyme MB catalytic concentrations, glycogen
phosphorylase isoenzyme BB mass concentrations in
this patient (see fig. l, patient b) were markedly higher
than in 16 uneventful cases and exceeded 100 g/l äs
early äs l hour after aortic unclamping, stayed high for 8
hours and decreased to baseline values within 24 hours.
Another patient (patient c, fig, 1) sustained extensive
perioperative myocardial infarction (creatine kinase iso-
enzyme MB peak level 340 U/l 48 hours after aortic
unclamping) and needed intraaortic balloon pumping
postoperatively. This patient died from cardiogenic
shock on postoperative day 3 and extensive periopera-
tive myocardial infarction was proved by autopsy. Gly-
cogen phosphorylase isoenzyme BB mass concentra-
tions in patient c steadily increased from aortic unclamp-
ing onwards and were markedly higher than in all other
patients from 16 hours after aortic unelamping onwards
(glycogen phosphorylase isoenzyme BB mass peak con-
centration: 2296.3 g/l 48 hours after aortic undamping,
see fig. 1).
Glycogen phosphorylase isoenzyme BB mass
concentrations in 2 patients with emergency
coronary artery bypass grafting for evolving
myocardial infarction
Both patients were transferred to our Institution for
emergency coronary artery bypass grafting for evolving
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Fig. l Glycogen phosphorylase isoenzyme BB mass concentra-
tions in patients with elective coronary artery bypass grafting.
a: uneventful patients (n = 16; data are given äs median, bars
indicate interquartile ränge);
b: a patient without perioperative myocardial infarction who sus-
tained postbypass cardiac failure;
c: a patient with extensive perioperative myocardial infarction who
died on postoperative day 3.
myocardial infarction. Both had a left main coronary
artery Stenosis and a history of angina at rest with ST-T
segment chänges and increased creatine kinase isoen-
zyme MB catalytic concentrations. Both patients
showed very similar time cgurses for perioperative cre-
atine kinase isoenzyme MB catalytic concentratiön (see
fig. 2a). Creatine kinase isoenzyme MB catalytic con-
centrations were already elevated befqre surgery (cre-
atine kinase isoenzyme MB 25 U/l and 44 U/l, respec-
tively)j stayirig high perioperatively (creatine kinase iso-
enzyme MB 23 U/l and 49 U/l 20 hours after äoftic
unclamping, respectively, see fig. 2a), By contrast, clin-
ical history äs well äs glycogen phosphoYylase isoen^
zyme BB mass release were markedly different. One pa-
tient (patient D, fig. 2b) already had elevated glycogen
phosphorylase isoenzyme BB mass concentrations pre-
operatively (glycogen^ phosphorylase isoenzyme BB be-
fore surgery: 60 £/1), but glycogen phosphorylase iso-
enzynte BB plasma concentrations decreased rapidly af«
ter aortic unclamping and were comparable to those in
patients with uneventful elective coronary artery bypass
grafting (glycogen phosphorylase isoenzyme BB 4 hours
after unclamping: 29.3 pg/l, glycogen phosphorylase
isoenzyme BB 16 hours after unclamping: 14.9 g/l).
Patient D complained of repeated and prolonged epi-
sodes of angina at rest, which were resistant to intrave-
nous nitroglycerin during the night before surgery. When
arriving in the operating theatre patient D was in cardio-
genic shock and needed inotropic support with catechol-
amines. Patient D was easily weaned from the bypass
after surgical revascularisation and did well postopera-
tively. Electrocardiographic monitoring in this patient
showed that no new Q waves developed perioperatively.
In the other patient (patient E, fig. 2b) glycogen phos-
phorylase isoenzyme BB mass concentrations were not
elevated before surgery (7.5 g/l). Patient E showed a
marked, persistent glycogen phosphorylase isoenzyme
BB increase (peak concentratiön: 414 g/l) from 8 hours
after unclamping until postoperative day 2. This patient
did not complain of angina during the immediate preop-
erative period and arrived in the operating theatre
haemodynamically stable. Patient E developed severe
cardiac failure after aortic unclamping and could be










1 2 3 4 8 12 16 20 24 36 48
Time after aortic unclamping [h]
Fig. 2 Time cpurse of creatine kinase isoenzyme MB and glyco-
gen phosphorylase isoenzyme BB in 2 patients with emergency
coronary artery bypass grafting for evolving myocardial infarction.
—·- patient (patient D): preoperative cardiogenic shock and un-
eventful postoperative clinical course.
—D— patient (patient E): stable haemodynamics preoperatively and
postbypass cardiac failure.
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istration of high doses of positive inotropic agents
(adrenaline 14 ^ig/kg · min, amrinone 350 Hg/kg · min).
This patient had a prolonged low cardiac Output syn-
drome postoperatively. Electrocardiographic monitoring
in this patient demonstrated the development of a new
left bundle branch block perioperatively.
Discussion
Creatine kinase isoenzyme MB catalytic concentration
is of limited sensitivity and specificity in the laboratory
diagnosis of perioperative myocardial ischaemia and
small perioperative myocardial infarctions (8, 9). Cre-
atine kinase isoenzyme MB catalytic concentration also
does not meet current needs for a highly sensitive
marker of minor myocardial injury, which is necessary
to compare different means of cardioprotection (10).
Preliminary data indicate that catalytic concentrations of
glycogen phosphorylase and glycogen phosphorylase
isoenzyme' BB (immunoinhibition by polyclonal anti-
bodies) are sensitive laboratory markers of perioperative
myocardial ischaemia in patients undergoing coronary
artery bypass grafting (11, 12). Therefore, we expected
glycogen phosphorylase isoenzyme BB mass concentra-
tion to offer advantages over creatine kinase isoenzyme
MB catalytic concentration in the evaluation of periop-
erative myocardial injury. In fact, glycogen phosphoryl-
ase isoenzyme BB mass peak concentrations, but not
creatine kinase isoenzyme MB catalytic concentration
peaks correlated significantly with aortic crossclamping
time. Furthermore, in a patient with cardiac failure after
aortic unclamping, who did not fulfill criteria for periop-
erative myocardial infarction, glycogen phosphorylase
isoenzyme BB mass concentrations, but not creatine ki-
nase isoenzyme MB catalytic concentrations were mark-
edly higher than in uneventful cases. Electrocardiogra-
phy was non-diagnostic in this patient, due to a preexist-
ing left bundle branch block, and could not be used to
support the diagnosis of myocardial injury, which was
based on clinical presentation. Nevertheless, ischaemic
myocardial injury not detected by creatine kinase isoen-
zyme MB catalytic concentration is the most likely ex-
planation for postbypass cardiac failure in this patient
who had an only mildly reduced preoperative left ven-
tricular ejection fraction and an aortic crossclamping
time of 65 minutes. The advantages of glycogen phos-
phorylase isoenzyme BB in the evaluation of periopera-
tive myocardial injury can be explained at least partly by
the higher relative increase of glycogen phosphorylase
isoenzyme BB compared with creatine kinase isoen-
zyme MB which was observed in patients with acüte
myocardial infarction (5). Due to their higher relative
increase, glycogen phosphorylase isoenzyme BB plasma
concentrations can be elevated considerably even after
limited myocardial necrosis, which does not necessarily
result in a detectable elevation in creatine kinase isoen-
zyme MB catalytic concentration. On the other hand,
these fmdings niight also support the hypothesis that
glycogen phosphorylase isoenzyme BB is released from
ischaemic but still viable myooardium, which does not
necessarily release other myocardial marker proteins. In
cardiomyocytes, glycogen phosphorylase isoenzyme BB
exists in association with glycogen, and the sarcoplas-
matic reticulum forms the sarcoplasmatic reticulun>gly-
cogenolysis-complex (13). During myocardial ischaemia
this complex is broken down (13). Glycogen phospho-
rylase isoenzyme BB is released intö the sarcoplasma,
which results in a large soluble cytosolic glycogen phos-
phorylase isoenzyme BB pool, and a high glycogen
phosphorylase isoenzyme BB concentration gradient be-
tween the sarcoplasma and the extracellular space. In
case of severe, but still reversible ischaemic injury of
the moyocardium, plasma membrane permeability is
also altered and soluble proteins may diffuse out of my-
ocytes and appear in the plasma (3, 14, 15).
Perioperative glycogen phosphorylase isoenzyme BB
mass, but not perioperätive creatine kinase isoenzyme
MB catalytic activity release correlated well with clin-
ical evidence of myocardial ischaemia in 2 patients with
emergency coronary artery bypass grafting for evolving
myocardial infarction. Glycogen phosphorylase isoen-
zyme BB plasma half life (4 to 6 hours; unpublished
data) is markedly shorter than creatine kinase isoenzyme
MB plasma half life (12 to 16 hours) (16). Therefore,
due to the very low ATd-value (12), glyeogen phosphpiyl-
ase isoenzyme BB plasma concentrations will return to
normal earlier than creatine kinase isoenzyme MB cata-
lytic concentrations in patients with myocardial infarc-
tion without ongoing ischaemia. Glycogen phosphoryl-
ase isoenzyme BB ineasufements will, therefore, iden-
tify patients with successful surgical revascularisation
earlier and more reliable than creatine kinase isoenzyme
MB determinations. Furthermore, glycogen phosphoryU
äse isoenzyme BB mass concentration increases eartier
than creatine kinase isoenzyme MB catalytic concentra-
tion in patients with acute myocardial infarction (5). The
differences in release kinetics and the possible release of
glycogen phosphorylase from ischaemic but still viable
myocardium might explain the advantages of glycogen
phosphorylase isoenzyme BB over creatine kinase iso*·
enzyme MB in the laboratory diagnosis of additional
perioperative myocardial injury in patients undergoing
emergency bypass surgery.
All 3 patients in whom glycogen phosphorylase isoen-
zyme BB, but not creatine kinase isoenzyme MB, indi-
cated myocardial injury received catecfaolamine therapy.
Experimental results indicate that without concomitant
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cell membrane damage, even high doses of adrenaline
do not cause a detectable glycogen phosphorylase re-
lease from cardiomyocytes (17). Therefore, it is unlikely
that catecholamine therapy alone, in the absence of addi-
tional myocardial injury, caused the glycogen phospho-
rylase release observed in these 3 patients. Only isoen-
zyme MM of glycogen phosphorylase has been isolated
from skeletal muscle (1). Cross-reaction of the glycogen
phosphorylase isoenzyme BB assay with MM and LL
isoenzyme was below 1% (7). Therefore, skeletal mus-
cle injury and liver damage do not contribute to the peri-
operative glycogen phosphorylase isoenzyme BB
increase observed in our patients. Haemoglobin and bili-
rubin do not interfere with the glycogen phosphorylase
isoenzyme BB assay used (7). Except for the patient
with perioperative myocardial infarction and cardio-
genic shock, who became anuric a few hours before
(death (postoperative day 3), no patient sustained periop-
jerative renal failure. In addition to the human myocar-
dium, significant amounts of glycogen phosphorylase
isoenzyme BB are also found in the brain (18). Signifi-
cant cerebral injury äs a source of increased glycogen
phosphorylase isoenzyme BB plasma concentrations
could be excluded with certainty in all patients. There-
fore, we conclude that the differences in glycogen phos-
phorylase isoenzyme BB plasma concentrations ob-
served in these 20 patients with coronary artery bypass
grafting reflect differences in the extent of myocardial
injury.
In summary, our results indicate that glycogen phospho-
rylase isoenzyme BB mass concentration is a very sensi-
tive marker of perioperative myocardial injury in pa-
tients undergoing coronary artery bypass grafting. Gly-
cogen phosphorylase isoenzyme BB mass measurements
may be particularly useful in the perioperative labora-
tory monitoring of myocardial ischaemia in patients un-
dergoing emergency coronary artery bypass grafting.
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